Figures & data
Table 1. Patients’ clinical characteristics.
Figure 1. Plasma and urine CCL2 levels between AKI and non-AKI patients at hospital and ICU admission. **p < 0.01; ***p < 0.001; ****p < 0.0001.
![Figure 1. Plasma and urine CCL2 levels between AKI and non-AKI patients at hospital and ICU admission. **p < 0.01; ***p < 0.001; ****p < 0.0001.](/cms/asset/a1cf98f4-55e6-460d-9ab0-282349c73baa/irnf_a_2313171_f0001_b.jpg)
Figure 2. The predictive performance of urine CCL2 for AKI by ROC analysis. (A) ROC curve. (B) AUC and prediction sensitivity and specificity.
![Figure 2. The predictive performance of urine CCL2 for AKI by ROC analysis. (A) ROC curve. (B) AUC and prediction sensitivity and specificity.](/cms/asset/d6562fd7-a561-4925-b98f-91c4cb9dd42d/irnf_a_2313171_f0002_c.jpg)
Supplemental Material
Download PDF (153.7 KB)Availability of data and materials
The data that support the findings of this study are available from the corresponding author upon reasonable request.